Foreign Drug Makers Present Lowest Price Global To Enter Chinese Reimbursement Scheme
In China, drug makers slash price and hope to recover the same in volume while some warn against commotion for the same in other drug markets.
drug manufacturer
GSK Is Parting With Its ‘Rare Disease Gene Therapy’ Unit Instead
Walmsley progressively moves on her promise of reshaping GSK’s portfolio in a strategic overhaul of the company whereby focusing on oncology.
